Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/64888
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUpcott, M.-
dc.contributor.authorChaprov, K. D.-
dc.contributor.authorBuchman, V. L.-
dc.date.accessioned2025-04-18T14:05:32Z-
dc.date.available2025-04-18T14:05:32Z-
dc.date.issued2021-
dc.identifier.citationUpcott, M. Toward a disease-modifying therapy of alpha-synucleinopathies: new molecules and new approaches came into the limelight / M. Upcott, K.D. Chaprov, V.L. Buchman // Molecules. - 2021. - Vol.26, №23.-Art. 7351. - Doi: 10.3390/molecules26237351.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/64888-
dc.description.abstractThe principal aim of this review is to critically evaluate the potential of therapeutic strategies that target the post-transcriptional steps of alpha-synuclein production and immunotherapy-based approaches to alpha-synuclein degradation in PD/DLB patientsru
dc.language.isoenru
dc.subjectbiologyru
dc.subjectbiochemistryru
dc.subjectalpha-synucleinru
dc.subjectbiomarkersru
dc.subjectrodent modelsru
dc.subjectParkinson’s diseaseru
dc.subjecttranslational researchru
dc.titleToward a disease-modifying therapy of alpha-synucleinopathies: new molecules and new approaches came into the limelightru
dc.typeArticleru
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Upcott_Toward_21.pdf1.09 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.